Drug trial targets debilitating Crohn's complications
NCT ID NCT03752970
Summary
This study tested whether a medicine called spesolimab could help adults with Crohn's disease who have painful fistulas near the anus. Twenty-seven participants were randomly assigned to receive either the drug or a placebo via an IV drip every four weeks for 24 weeks. Doctors tracked whether the fistulas closed and stopped draining to see if the treatment was effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AKH - Medical University of Vienna
Vienna, 1090, Austria
-
Amsterdam UMC, Locatie AMC
Amsterdam, 1105 AZ, Netherlands
-
Centre Hospitalier Universitaire de Liège
Liège, 4000, Belgium
-
Herlev and Gentofte Hospital
Herlev, 2730, Denmark
-
Hospital Universitari de Girona Doctor Josep Trueta
Girona, 17007, Spain
-
Inje University Haeundae Paik Hospital
Busan, 48108, South Korea
-
Semmelweis University
Budapest, 1088, Hungary
-
UZ Leuven
Leuven, 3000, Belgium
-
Universitätsklinikum Erlangen
Erlangen, 91054, Germany
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
Conditions
Explore the condition pages connected to this study.